Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014


Social Media in the Pharmaceutical Industry

22 Jan 2014 - 23 Jan 2014 - London, UK



Bookmark and Share


SMi is pleased to present the 6th instalment in the sell out Social Media Pharmaceutical conference series which returns to London on 22nd and 23rd January 2014.

With health at the top of any patient’s agenda the opportunity for health professionals to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Join our panel of leading industry speakers, from Big Pharma companies to cutting edge developers at the heart of social media technology today. You simply cannot afford to miss out.

Reasons to Attend:

Learn about the cutting edge developments in social media including personalised marketing techniques, mobile platforms, remote monitoring and open stakeholder engagement.

Share ideas with leading technology providers; discuss the industry requirements and learn what technological solutions are available.

Hear how major pharmaceutical companies are actually applying the latest developments in social media in a practical way.

Analyse how social media will allow your organisation to better communicate and interact with your stakeholders.

Expert Speaker Line-up includes:

Doris Cesares, Director of Communication, AESEG

Sherri Matis-Mitchell, R and D, Astra Zeneca 

Neeraj Goel Mittal, Business Intelligence Manager, AbbVie 

Dr. Alfred R. Steinhardt, Founder, Alfred Steinhardt Consulting

Piotr Wrzosinski, Digital Marketing, Roche 

Ben Furber, Asthma UK

Claire Perrin, European Brand Leader, Eli Lilly

Alexandra Fulford, Consultant, Pharmaguapa 

Gizem Bicakci, eMarketing, Boehringer-Ingelheim 

Matt Evans, Chief Medical Officer, Health Unlocked 

Todd Kolm, Vice-President, Head of Global Digital Strategy, Sanofi

James Finney, Project Manager, Global Comm. Services, Novozymes Biopharma

Shona Davies, Communication and Programme Leader, Merck

For further details and to register, visit http://www.smi-online.co.uk/goto/2014social-media-pharma26.asp 

Alternatively contact John Collins on +44 (0)20 7827 6000 or email jcollins@smi-online.co.uk 

Join the conversation on Twitter @smigrouppharm | #pharmasocialmedia



Further information
Scientific News
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.
Game Changing Antibacterial Drug Research
Researchers publish report on the synthesis of a newly discovered “game-changing” antibiotic, Teixobactin.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
New Way of Displaying 3D Molecular Structures
Metal-organic frameworks provide a new platform for solving the structure of hard-to-study samples.
Agent Blocks Pain Without Morphine's Side Effects
Scientists have synthesised a molecule with specific pain-relief properties and has shown its efficacy in mice.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!